2143443-A1 is referenced by 35 patents and cites 2 patents.

[en] The present invention provides a novel therapeutic or preventive method, a pharmaceutical composition and use thereof, that exhibit superior anti-obesity effects (body weight-reducing (losing) effects and/or body fat mass-reducing effects). Specifically, the present invention provides a pharmaceutical composition comprising the combination of a dipeptidyl peptidase 4 inhibitor and a sweetener having a GLP-1 secretion-stimulating action, as well as use thereof for the manufacture of a medicament. The present invention also provides a method for treating or preventing obesity, comprising administering an effective amount of (a) a dipeptidyl peptidase 4 inhibitor and (b) a sweetener having a GLP-1 secretion-stimulating action to a patient suffering from symptoms of obesity.

Title
[fr] UTILISATION COMBINÉE DE COMPOSÉ INHIBITEUR DE DIPEPTIDYLPEPTIDASE IV, ET DADOUCISSEUR
[de] KOMBINIERTE VERWENDUNG EINER DIPEPTIDYL-PEPTIDASE-IV-INHIBITOR-VERBINDUNG UND EINES SÜSSSTOFFS
[en] COMBINED USE OF DIPEPTIDYL PEPTIDASE IV INHIBITOR COMPOUND AND SWEETENER
Application Number
EP20080739785
Publication Number
2143443 (A1)
Application Date
April 3, 2008
Publication Date
January 13, 2010
Inventor
MATSUSHITA CHIAKI
JP
ISHIHARA TOMOMI
JP
SHIOTANI MASAHARU
JP
Assignee
MITSUBISHI TANABE PHARMA
JP
IPC
A61P 43/00
A61P 3/10
A61P 3/04
A61K 31/702
A61K 31/7004
A61K 31/54
A61K 31/496
A61K 31/40
A61K 31/047
A61K 45/06
View Original Source Download PDF